Invitrogen™ Human PLAC1 Synthetic Peptide

Catalog No.	Quantity
PEP1158	50 μg

Catalog No. PEP1158 Supplier Invitrogen™ Supplier No. PEP1158

Description

Synthetic Peptide

PLAC1 Synthetic Peptide, PEP-1158, from Invitrogen.

PLAC1 was initially identified as a protein expressed specifically in the placenta and other cells derived from the trophoblast lineage during embryonic development, but has also been found to be expressed ectopically in a wide range of human malignancies, particularly breast cancers. PLAC1 is a membrane-associated protein that is thought to serve a receptor-like function modulating cell-cell or ligand receptor interactions unique to the maternal-placental interface. Decreased expression of PLAC1 is associated with decreased expression of cyclin D1 and reduced expression of AKT kinase, which, combined with the fact that PLAC1 is expressed on the surface of cancer cells, suggests that PLAC1 may be an effective candidate for immunotherapeutic treatments of cancer.

Specifications

• Gene ID (Entrez): 10761
• Species: Human
• Purification Method: purified
• Accession Number: Q9HBJ0
• Common Name: Human PLAC1
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: PLAC1
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS